« Back
Home /
Loureirin B

Loureirin B

Item no.	TMO-T3876-5mg
Manufacturer	TargetMol
CASRN	119425-90-0
Amount	5 mg
Quantity options	100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mL 1 mg 25 mg 2 mg 50 mg 5 mg
Category	Oncology Neuroscience Neural Lineage Markers Reagents & Chemicals Molecules By Organ Colorectal Cancer Neurodegeneration Markers
Type	Molecules
Specific against	other
Citations	1. Bai X, et al. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-beta/Smad pathway. Exp Dermatol. 2015 May;24(5):355-60.
Smiles	COc1cc(OC)c(CCC(=O)c2ccc(O)cc2)c(OC)c1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	inhibitor
Shipping Condition	Cool pack
Available
Manufacturer - Targets	ERK\|\|\|PAI-1\|\|\|Potassium Channel\|\|\|JNK
Shipping Temperature	Cool pack
Storage Conditions	-20
Molecular Weight	316.35
Description	Loureirin B can downregulate the expression of fibrosis-related molecules by regulating MMPs and TIMPs levels, inhibit scar fibroblast proliferation and suppress TGF-β1-induced fibrosis, during which TGF-β1/Smad2/3 pathway is likely involved.
Pathways	MAPK\|\|\|Membrane transporter/Ion channel\|\|\|Metabolism

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

TMO-T3876-5mg-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 5 mg

available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question